Literature DB >> 120422

Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.

T G Rudd, D R Allen, F D Smith.   

Abstract

The biologic and imaging characteristics of Tc-99m MDP and Tc-99m HEDP were compared in ten patients: Tc-99m MDP exhibited lower blood activity, lower 4-hr urinary excretion, and higher normal bone-to-background ratio. Assessment of overall image quality also favored Tc-99m MDP, indicating that the normal skeleton is better visualized with this agent. The total number of lesions seen (18) was not large enough to allow critical comparison of relative lesion-detecting efficacy. However, discrepancies between the two agents were observed, suggesting additional evaluation of the relative lesion-detecting efficacy of these two bone agents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 120422

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Factors influencing bone scan quality.

Authors:  F G Adams; A W Shirley
Journal:  Eur J Nucl Med       Date:  1983

Review 2.  The role of skeletal scanning in clinical oncology.

Authors:  J H McKillop; I R McDougall
Journal:  Br Med J       Date:  1980-08-09

3.  Biological and imaging characteristics and radiation dose rates associated with the use of technetium-99m-labelled imidodiphosphate in the horse.

Authors:  L J Riddolls; G G Byford; S L McKee
Journal:  Can J Vet Res       Date:  1996-04       Impact factor: 1.310

Review 4.  Mesenchymal Stem Cells: The Magic Cure for Intraventricular Hemorrhage?

Authors:  Won Soon Park; So Yoon Ahn; Se In Sung; Jee-Yin Ahn; Yun Sil Chang
Journal:  Cell Transplant       Date:  2016-11-30       Impact factor: 4.064

5.  Diphosphonate bone scanning agents--current concepts.

Authors:  I Fogelman
Journal:  Eur J Nucl Med       Date:  1982
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.